Such a focus would reside in the Purkinje conducting system, since ventricular myocardial fibers lack pacemaker properties except under unusual circumstances. The characteristic attribute of a pacemaker cell is an unstable potential with slow depolarization during diastole. When the diastolic depolarization reaches a critical threshold an action potential is initiated. Control of heart rhythm generally belongs to the pacemaker with the highest level of automaticity. Increase in rate of diastolic depolarization, rise in threshold potential, and reduction in maximum diastolic potential each will result in an acceleration of discharge rate ( fig.   1 ).2 Reentry as the mechanism for VT has been deemed unlikely because of the absence of a pathway of sufficient length to accommodate sustained reexcitation. If there were great delay in impulse propagation, such as recorded from cells of the atrioventricular (A-V) node (0.02 m/sec), and unidirectional block, reentry would be a possible mechanism. Recently, a biologic model has been developed in which unidirectional block and marked slowing of conduction occur in small segments of canine Purkinje fibers. These short segments manifest reentrant excitation in the absence of premature stimulation.3 It also has been observed that two blocked impulses in a branching Purkinje system can create by summation a new impulse with a conduction velocity as slow as 0.02 m/sec. In a different model, closed loops of depressed ventricular conducting fibers 12-35 mm long produce single and sustained impulse propagation around the loop (single and sustained circus movement, respectively) .4 Thus the prerequisite conditions for reentry have been fulfilled. Finally, Sasyniuk and Mendez5 have shown that a sequence of two or three electric stimulations can provoke unidirectional conduction block at the Purkinje fiber-myocardial junction with marked abbreviation of the action potential proximal to the site of block thereby favoring reexcitation. Indeed, clinical evidence, to be discussed, indicates that a majority of VENTRICULAR TACHYARRHYTHMIAS
Figure 1
Schematic presentation of action potential of pacemaker fiber. TP= threshold potential; MDP= maximum diastolic potential; a = control; b, c, d =modes of decreasing heart rate: (b) by slowing rate of diastolic depolarization, (c) increasing MDP, and (d) decreasing threshold potential. episodes of VT in patients with coronary heart disease are probably due to reentrant activity.
Clinical Background
Around the turn of the century, McKenzie, by means of the phlebogram, separated paroxysmal tachyeardias into those of atrial and ventricular origin. 6 Lewis, who reported the first clinical case, also pioneered the development of an experimental model for VT .7 In dogs ligation of a coronary artery near its origin yielded paroxysmal and then sustained VT. No data exist on the precise incidence of the paroxysmal variety of VT. Episodes are usually brief sequences of three to 10 consecutive cycles unassociated with symptoms. Since the routine 12-lead electrocardiogram provides less than 1 min of monitoring information, the majority of these short-lived paroxysms are missed. A similar experience has been noted with ventricular premature beats (VPB's ) . ' 1 Probably the highest incidence of VT occurs during acute myocardial infarction. The majority are brief paroxysms and are noted in 16-40% of patients. 8 The arrhythmia has the highest incidence during the first 6 hours after onset of acute myocardial infarction and thereafter recedes sharply. Thus, Morgensen9 noted that if patients were admitted within 3 hours following onset of symptoms, 39% exhibited VT; if admitted after 24 hours the incidence was only 3%. VT occurs with equal frequency whether the lesion is anterior or dia-Circulazion, Volume XLVII, June 1973 phragmatic in location. It is favored by congestive heart failure and infarcts of large size.
Two variants of VT are observed during acute myocardial infarction. The first type is the familiar rapid tachycardia occurring usually in brief salvos. The second type is at a slow rate and has been designated "idioventricular rhythm";10 however, unlike idioventricular escape rhythms, discharge is faster than that of the underlying sinus mechanism. It occurs most frequently in the presence of bradycardia or during the slow phase of sinus arrhythmia. Fusion beats and A-V dissociation are observed in two thirds of cases" (fig. 2) . While this arrhythmia has been regarded as a benign disorder,10' 11 in two patients it was the only prodrome to VF. Not infrequently, in the patient with acute myocardial infarction, VT is the result of medical ministration. Improper usage of such drugs as isoproterenol, atropine, and digitalis may be implicated. A cause not immediately recognized is dislodgment of a catheter. A central venous line may shift forward or more rarely a pulmonary artery catheter may move backward into the right ventricle. These arrhythmias are resistant to antiarrhythmic drugs. After hospital discharge, short bouts of VT were detected in 2.6% of patients during 10 hours of ambulatory monitoring. (Wolf MA, Peeler N, Lown, B: Unpublished data.)
Sustained VT unrelated to acute myocardial infarction occurs generally beyond the fifth decade and preponderantly in males: 75% suffer from CHD, VT, although it frequently can be suspected at the bedside, never cani be diagniosed with certainty. An arrhythmia may be presumed to be VT when cardiac function is significantly compromised though the ventricular rate is less than 160/mmn. This surmise is more likely when the victim is beyond middle age and is known to have coronary heart disease. Further credence is lent to the diagnosis when the episode is of abrupt onset, and VPB's were present prior to the attack. In the physical examination one focuses on three features: (1) asynchrony of ventricular activation, (2) the A-V sequence, and (3) response to carotid sinus stimulation.
Asynchrony of ventricular activation is suggested by the wide splitting of first and second sounds. A third sound gallop and intermittent fourth sound add to the multiplicity of sounds,'5which are best appreciated at the lower left sternal border. The first sound may be accentuated while the second sounid, reflecting reduced arterilal pressure, is diminiished and at times may be inaudible. The first sound can alternate in intensity in successive cycles and thus may be taken as a second sound leading to underestimation of the heart rate.
Circulation. Volume XLVII. June 1973 1366 VENTRICULAR TACHYARRHYTHMIAS A-V dissociation is one of the most important features of VT. It is indicated by the presence of intermittent cannon a waves in the jugular pulse. Changing intensity of the first sound at the apex likewise argues for a changing A-V activation. Peak pressure as well as stroke volume in episodic beats with a normal sequence of A-V contractions will be augmented. Such potentiation can be detected while determining blood pressure during slow deflation of the cuff. 16 The above signs are characteristic of A-V dissociation of whatever cause and are absent when during VT the atria are activated retrogradely or the mechanism is atrial fibrillation.
During VT carotid sinus massage is without effect on the ventricular rate and does not terminate the disorder; however, it may slow the atrial rate. This is best appreciated during electrocardiographic monitoring with special leads.
Electrocardiographic Aspects
The routine electrocardiogram has long been viewed as the ultimate arbiter for the mechanism of a tachyarrhythmia. The criteria for diagnosing VT are those proposed by Robinson and Herrmann17 a half century ago. The importance of three features were stressed: (1) abnormal ventricular complexes with a duration of 0.12 sec or more, at times varying in morphology due to episodic superimposition of P waves; (2) dissociated atrial rhythm with a slower rate than the ventricular rhythm; and (3) ventricular ectopic beats with complexes similar to those of the paroxysm observed before or after the tachycardia. Much clinical experience gained in the intervening 50 years attests to the inadequacy of these criteria. The electrocardiogram rarely provides unequivocal evidence to sustain the diagnosis of VT. Indeed, Kistin,'8 a student of this disorder, stated that the only arrhythmias one can ascribe to the ventricle without doubt are VF and ectopic mechanism produced by direct ventricular stimulation.
Rate and Regularity
VT may be defined as a sequence of three or more ventricular extrasystoles at rates ranging from 150 to 250/min. The prevailing view is that a rate of 100 or more is sufficient for diagnosis. 12 Classical VT usually has a beat-to-beat variation of less than 0.33 sec. Irregularities are often observed at the initiation and termination of the disorder and following antiarrhythmic drugs. The greatest variability in rate is observed in the slow VT's which follow acute myocardial infarction.
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Within one brief salvo, rates have been recorded ranging from 94 to 188/min.19
Abnormal Ventricular Complex
A bizarre and prolonged QRS complex is not a decisive criterion for distinguishing ventricular from supraventricular tachycardia. Altered QRS configuration may be due to preexisting bundle or fascicular block; it may be the consequence of rateinduced aberrant conduction; or it may stem from transit of the impulse over an anomalous pathway as is present in Wolff-Parkinson-White (W-P-W) syndrome. Diagnosis of VT is further complicated by the fact that an ectopic focus originating in the ventricular septum may exhibit slight, if any, alteration in morphology or duration.
When the pattern of ventricular abnormality is right bundle-branch block, especially when the complex is triphasic in lead V,, Marriott and Sandler20 have indicated the great likelihood of aberrant conduction. However, a majority of episodes of VT originate in the left ventricle with the resultant pattern simulating right bundlebranch block. When the rate of tachycardia is variable, lessening of QRS abnormality in the cycles with longer interectopic intervals argues for aberrant conduction rather than a ventricular ectopic disorder. Conversely, persistence of bizarre QRS's with wide variations in cycle length suggests VT rather than aberration.
Capture and Fusion
When a normal QRS appears among the abnormal complexes of the tachycardia, transit over the bundle of His from a supraventricular site is suggested ( fig. 3 ). In order to discharge the ventricles, which have recovered from their refractory period, the supraventricular beat must arrive earlier than the ectopic focus. Such transient capture, usually sinus, with a cycle shorter than the dominant interval suggests that a supraventricular focus, even faster than the dominant rhythm, can be sustained without aberration. By inference the abnormal QRS morphology must be due to an ectopic mechanism. The conducted supraventricular beat may arrive coincident with discharge of the ectopic focus, in which case complexes may emerge with configurations intermediate between normal and those of the VT. 21 The degree of QRS abnormality will vary depending on the timing of the capture beat relative to the ectopic focus.
Identification of fusion beats that are consistently related to atrial complexes is a valuable diagnostic 1367 LOWN ET AL. Figure 3 Rapfid VT at rate of 200/wnin in platient with acute myocardial infarctioni. The first arrow points to a fusion, beat anid occurs at a cycle interval niearly identical to the interectopic inzterval. The second arrow itndicates a comp)letely captured beat appl)earitig at a shorter cycle length than the tachycardia. featuire; sinlce the suipraventricular part of the complex has traversed normal conduction pathways, the deformation must be due to coincident ventricular depolarization.
Hovever, even fusion and capture beats are not consistenltly decisive criteria. There are several exceptional circumstances where such beats may be noted in the absence of VT: (1) in supraventricular tachycar.dia, ventricular ectopic beats may simulate capture beats; (2) in W-P-W syndrome with tachyarrhythmia, episodic impulse propagation over the nioimal A-V pathway su(ggests capture; and (3) during a supraventricular tachycardia with aberration, atrial or junctional premature beats may be propagated normally wvhen discharging durinig a "ecsupernormal phase of conduction."
A-V Dissociation
Independent atrial activity can be identified in 20% of cases of VT. 22 However, the absence of d,ssociation does not nile out this arrhythmia. Lewis7 demonstrated the great frequiency of retrograde atrial activation in experimental VT resulting from coronary artery ligation. Using esophageal leads, Kistin2: founid that 80% of ventricular ectopic beats conducted retrogradely to the atria. Antegrade and retrograde conduction times were of the same duration. In 21 patients with paroxysms of VT, 14 slhowed a ventriculoatrial (V-A) activation setiuence raniging from 1:1, to varying degrees of V-A block. Presence of retrograde conductioni was independenit of the ectopic rate and was observed when the rate was as fast as 207 beats/min. When VT was induced durinig cardiac catheterization, retrograde conduction was noted frequently.24 The QRS-P' interval always was longer than 0.1 sec. The above cited studies involved patients with brief paroxysms; it is uncertain whether retrograde coniduction is also common when the arrhythmia is long lasting.
An additional factor complicatinig the diagnosis of VT is the observation that A-V dissociation can occur with A-V junctional rhythms.25 Thus, in an established tachyarrhythmia, the intraatrial electrogram may not be helpful. If P waves are identified at a slow rate and independent from that of the taelhyarrhythmia, the mechanism may be junctional.
If P waves occur in a fixed V-A block pattern, the arrhythmia may still be junctional. If atrial and ventricular rates are equal, the proximity of P to QRS is not proof of antegrade conductioni for this may be the restult of prolonged V-A conduction time. Likewise, the nearness of the atrial complex to the preceding QRS does not necessarily indicate retrograde conduction as this may occur during supravenitricular tachycardia with first-degree A-V block ( fig. 4a ).
A supraventricular origin is more readily deduced wheni the arrhythmia is intermittent and starts with an ectopic P wave. The mechanism is then atrial or junctional with more rapid retrograde thain antegrade conduction. If the arrhythmia starts with a QRS complex and the V-A duration is less than 0.1 see, the mrechan2ism originates in junctional tissue.
In the presence of a 1:1 A-V response, slowing of the atrial rate by carotid sinus stimulationi without affecting the ventricular rate suggests a ventricular or junctional mechanism ( fig. 4b ).
Additional Diagnostic Aids
The initroduction of a technic for recording His bunidle potentials2°; may facilitate the diagnosis of VT. This technic permits mapping of sequential activation within the conduction system. When a monitorinlg electrode is positioned at the base of the atrial septum, in the middle of the tricuspid valve area, the His potenitial appears as a rapid biphasic Circulation, Volume XLVII, June 1973 P P 'P P P P p P p p P A Figure 4 (Top) Intraatrial electrocardiogram does not distinguish between supraventricular and ventricuflar tachycardia. In this patienit the miechanism cotuld have been an atrial or julnctional mechanism with ventrictular aberratiorn or VT with 1:1 retrograde conduction. (Bottom) Sante arrhythmia as shown in fig. 6 . Propranolol and carotid sinus pressure induced 2:1 V-A block ruling out atrial tachycardia as the mechanism. or triphasic deflection. When the rhythm is sinus, this deflection is situated between P and QRS complexes. In a supraventricular rhythm the His potential precedes ventricular depolarization while in a venitricular rhythm it follows and has an altered morphology.
Monitoring of the ambulatory patient following termination of a tachyarrhythmia provides a rich harvest of ect-opic activity. The diagnosis of VT is strengthened when ventricular premature beats have a morphology similar to that of the prevailing complex during the arrhythmia. At times when the mechanism has been judged as ventricular, monitoring demonstrates an unaltered QRS complex at the inception of paroxysm indicating a supraventricular site of origin ( fig. 5 ). When the arrhythmia is not manifest during passive monitoring, vigorous exercise on a motorized treadmill or bicycle ergometer may precipitate the tachyarrhythmia. Usually the paroxysm is short lived, thereby providing data as to onset and termination ( fig. 6 ).
Diagnosis of VT
The clinician not adept at recording of intracardiac electrograms or lacking up-to-date monitoring devices need not despair. A systematic examination Cirulatizon, oiu'tne XLVII, June 1973 of all clinical and electrocardiographic evidence generally provides a reasonable "working" diagnosis. The diagnosis of VT is favored in the patient with CHD if the tachyarrhythmia demonstrates a wide, altered QRS complex and evidence of A-V dissociation. Support is added if VPB's, either before or after a paroxysm, possess a similar morphology while the presence of capture or fusion beats strengthens this conclusion. Diagnostic measures which unduly delay treatment are not justified. The physician's primary responsibility is to terminate the arrhythmia expeditiously and safely. In fact, the tachyarrhythmia can be abolished readily whether the focus is atrial, junctional, or ventricular, whether the underlying mechanism is reentrant or ectopic.
Treatment
There are two objectives to therapy: to abolish the arrhythmia and to prevent its recurrence. These will be discussed in turn.
Abolition of Tachycardia
Before the 1950's, quinidine was the mainstay of therapy. When it failed, success occasionally was This patient was long considered to have recurrent VT because of A-V dissociation and a bizarre ventrictlar complex. However, monitoring captured onset of a paroxysm with an unaltered QRS morphology (middle strip). The mechanism most likely is junctional with retrograde block and aberrant ventricular conw duiction.
achieved with some of the following measures:
atropine, morphine, magnesium sulfate, papaverine, Rest potassium, pressor agents, digitalis glycosides, chloroquine, anid antazoline. There is uncertainty as
1 mm/sec Figure 6 Motorized treadmill exercise evoked five ventricular ectopic beats preceding a salvo of VT. Data reduction by means of a "poor mnn's" EBD (see text).
Circulation. Volumne XLVII, June 1973
Time 1370 VENTRICULAR TACHYARRHYTHMIAS to the efficacy of these agents as frequently supraventricular and ventricular disorders were not rigorously distinguished. The use of quinidine, especially by the intravenous route, is associated with an inordinately high incidence of adverse reactions, including VF. 27 With its introduction, procaine amide became the therapy of choice for VT. 28 In a collected series of 100 cases, procaine amide administered intravenously proved effective in 78 cases.29 Experience with a large number of patients having VT indicates that procaine amide is not a suitable drug. Like quinidine it compromises myocardial performance. In order to avoid major adverse reactions, the drug is given in increments of 50 mg at intervals of 2-5 min. Achieving a sinus mechanism may require 1 or more hours. Sincet the arrhythmia frequently develops in patients with severe myocardial disease, continued tachycardia may induce further heart damage.
The nearly instantaneous restoration of sinus rhythm by means of cardioversion, the high incidence of success, simplicity of the procedure, and paucity of complications suggest the use of electric discharge as the preferred therapeutic method. However, since cardioverters are not universally available, many physicians are inexperienced in their use. Furthermore, as it is necessary to perform cardioversion under light anesthesia, a brief trial of an antiarrhythmic agent is warranted as a first approach. Lidocaine Ease of administration, low incidence of complication, and promptness of effect have popularized the use of lidocaine for suppressing diverse ventricular arrhythmias. This agent is a synthetic local anesthetic about four to five times as potent as procaine amide.30 When given intravenously, its effect is observable in 15-0 sec due to rapid diffusion and cell membrane penetration. The primary pathway of elimination is by hepatic degradation to free and conjugated phenols which accounts for 70% of the drug's metabolism. The blood level is inversely related to the cardiac index and hepatic blood flow and the drug is cleared from the circulation in about 20 min.31 Less than 10% of unaltered drug is found in the urine. Unlike procaine amide, lidocaine does not decrease right or left ventricular contractile force, arterial pressure, or cardiac output. It does not increase left ventricular end-diastolic pressure when given intravenously in therapeutic doses of 100 mg or less.30
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It generally is assumed that all local anesthetic agents act in a similar manner, namely, as membrane stabilizers which retard or prevent ionic movement across cell membranes.32 Therapeutic doses of lidocaine exert little effect on the action potentials of the SA node, the specialized atrial tissues, or atrial muscle fibers. In canine Purkinje fibers lidocaine shortens action potential duration and refractoriness, but prolongs recovery of excitability relative to its effect on the duration of repolarization ( fig. 7 ) .33 These actions are more marked for the specialized ventricular conducting system than for the ventricular myocardial fibers. At therapeutic concentration, it exerts either no effect or induces a small increase in the maximal rate of depolarization (phase 0) ( fig. 8 ), overshoot, and conduction velocity. 34 Recently it has been demonstrated that lidocaine increases the threshold to VF induced electrically. 35 In the treatment of VT an intravenous bolus of 50 mg of lidocaine will result in blood levels of 0.3-1.8 gg/ml. Antiarrhythmic effects usually require concentrations of 1.2-6.0 gug/ml.36 If the tachycardia is not terminated, an increment of 100 mg may be given and repeated within 2 min. If VT still persists little is to be gained by additional doses of lidocaine. This agent is especially appropriate in the patient with acute myocardial infarction and is effective in reverting about 80% of episodes of VT.37
Since lidocaine is eliminated by the liver, it can be employed even in the patient with oliguria. While lidocaine is being administered, the patient is readied for cardioversion should the drug fail.
Cardioversion
In an early report on the use of this technic to terminate VT, 31 of 32 episodes (97%) were successfully treated. 38 These results are especially impressive as they involved patients who failed to respond to large doses of antiarrhythmic drugs.
A review of our contemporary experience, exclusive of attacks occurring within 48 hours of the onset of acute myocardial infarction, shows cardioversion to have proved effective in 98% of 116 episodes of VT in 39 patients. Of these 31 were males and eight were females. Thirty-six of the patients had CHD and 11 had sustained an acute myocardial infarction within the week. The longest duration of continuous VT was 34 days. Of the 39 patients, 24 had a single bout of arrhythmia, while the remaining 15 had more than one attack. Schematic changes induced by antiarrhythmic drugs on the ventricular action potential and electrocardiogram. Numbers represent phases of action potential; the solid line is the control. Action potential duration and Q-T interval are shortened in B and prolonged in C. Quinidine and procaine amide slow the rate of depolarization (phase 0) and prolong the QRS interval. Although DPH has been shown to shorten the Q-T interval, effect on ventricular action potential duration has not been established.
The technic of cardioversion has been previously described. 39 Whether analgesia is employed depends largely upon the threat to immediate survival. It is wise to employ a sedative drug such as diazepam; otherwise the fear and discomfort of the electric discharge may predispose to further tachycardia. When the patient is gravely affected by the tachycardia, diazepam may be given in three 5-mg doses at 2-min intervals. Effective amnesia results in most patients.
In the patient with CHD and VT, low electric energies are uniformly effective. During the past 3 years, the initial cardioversion energy employed was 10 w-sec or less. In 41 of 42 episodes (98%), sinus rhythm was restored with these low levels of discharge (table 1) . Of 25 episodes treated with 1 w-sec or less, 19 (76%) were restored to sinus rhythm. In two patients, 0.5 w-sec sufficed to restore sinus rhythm ( fig. 9a ). These findings suggest that a single threshold pulse delivered to an appropriate myocardial site may suffice to terminate VT. Indeed, this has been demonstrated by Wellens et al. 40 In five patients, four of whom had CHD, VT was initiated by a single ectopic stimulus during right ventricular pacing. The tachycardia could be terminated by single or two closely coupled right ventricular extrasystoles. Schematic of the effects of antiarrhythmic drugs on the membrane responsiveness curve. Solid line represents control values. Therapeutic doses of DPH and lidocaine cause no change or shift the curve but slightly to the left. Quinidine, procaine amide, and high doses of lidocaine shift the curve down and to the right. All these agents shift the least negative membrane potential from which a response can be elicited to a more negative value.
Our findings as to the effectiveness of low-energy discharge provide circumstantial evidence that spontaneously occurring VT, in patients with CHD, may be the result of circus movement. An energy discharge of 1 w-sec transthoracically is equivalent to a threshold stimulus delivered through a catheter. That such a small pulse abolishes the tachycardia indicates that it depolarizes a circuit over which the arrhythmia traverses. It would be hard to account for such an effect if the rhythm disorder resulted from a single discharging focus. In three of 39 patients, who were free of coronary disease, high discharge levels were required to abolish the tachycardia. This suggests that a different mechanism is responsible for VT in the absence of an ischemic or infarcted region of myocardium.
Circulation, Volume XLVII, Failures and complications with cardioversion have been unusual. One patient, without demonstrable heart disease, who suffered from recurrent VT, on eight occassions required 800 w-sec ( fig. gb ) during a period of 3 decades. Two attacks could not be reverted even with multiple shocks of 800 w-sec. (These high energies were made available by connecting two cardioverters in parallel.)
There is one exceptional circumstance when the use of low-energy shock is not advisable. When the QRS complex is bizarre and wide and cannot be readily distinguished from the T wave, there is a 50% chance that synchronization will be with the apex of the T wave. This favors the emergence of VF, especially when low-energy discharges are employed. When encountering such a problem, our 1373 1 -Monitor L 11 Figure 9 (Top) The lowest energy employed 0.5 w-sec transthoracically, converted VT to sinus rhythm. (Bottom)
In onie patient nine episodes of VT could not be terminated except at energies of 800 w-sec. This massive shock induces prolonged muscle tremors. current practice is to switch to the defibrillator mode and randomly deliver a shock of 100 w-sec.
Other Drugs
Whern lidocaine and cardioversion fail, antiarrhythmic drugs such as diphenylhydantoin and procaine amide need be considered. Bigger and co-workers4l report that diphenylhydantoin consistently reverted VT in eight patients. They emphasize that a critical plasma level, ranging from 10 to 18 pg/mg, must be exceeded in order to suppress the arrhythmia. They suggest that diphenylhydantoin be administered intravenously in a dose of 100 mg every 5 min until reversion or undesirable side effects have developed. Serum concentration increases by about 3-4 ug/ml after each dose; generally 10 gg/ml is reached when about 4 mg/kg or about 300 mg has been given. This method has several drawbacks; it may require 1 hour or more to reach a therapeutic level, it may lead to hypotension when the cumulative dose exceeds 500 mg, and furthermore, there is no evidence that diphenylhydantoin is effective when simpler measures such as lidocaine and cardioversion have failed. Procaine amide has been utilized when the above measures have failed.
If the approach promulgated in this report is followed small doses of lidocaine will prove effective in 80% of VT. Cardioversion will restore sinus mechanism in 19%; while in the remaining 1% it will be necessary to resort to large doses of antiarrhythmic drugs.
Prevention of Recurrences
The problem of prophylaxis against VT is largely a new chapter in therapeutics. In the past, the patient usually did not survive many such recurrences. Two developments are responsible for the increased incidence of this condition: (1) The patient who is readily restored by means of cardioversion lives and is susceptible to recurrences.
(2) The coronary care unit permits salvage of patients with electrical instability, thereby providing a population more prone to VT.
The therapeutic approach is in part determined by whether the patient is having acute myocardial infarction. Attacks may be numerous and require as many as 100 cardioversions in a single day. In such a case it is imperative to rule out iatrogenic or metabolic factors. Perhaps the most important iatrogenic cause is mechanical stimulation of the right ventricle by an improperly placed catheter, the result of migration of either a central venous line or Swan-Ganz pulmonary artery catheter. Refractoriness of the tachycardia to various antiarrhythmic drugs should suggest this possibility. Xray provides confirmation and cure is almost miraculous and instantaneous following withdrawal of the offending line. Acid-base abnormalities, hypoxia, and hypokalemia may also account for frequently recurring and refractory arrhythmia.42
In the patient with acute myocardial infarction, lidocaine is the drug of choice for treating as well as preventing VT. Procaine amide is the drug of second choice. When this agent also proves unavailing, overdrive pacing used in conjunction with drugs is nearly uniformly successful. 43 Only infrequently is it necessary to resort to bretylium tosylate or other agents.
Circulation, Volume XLVII, June 1973 1374 VENTRICULAR TACHYARRHYTHMIAS When VT develops in the absence of myocardial infarction, it may recur over prolonged periods. One of our patients has had arrhythmia over 30 years. We have recently studied 32 patients who experienced 456 bouts of VT. Of these, 406 episodes were terminated by means of cardioversion, while the remaining 50 were controlled with drugs. (The attacks of VT were treated in other hospitals where cardioversion is preferred to the use of lidocaine.)
Only the broad principles for evolving prophylactic program will be dealt with in the present communication. These principles are embodied in the following didactic outline.
Ambulatory Monitoring
Frequent monitoring, by means of a portable tape system, helps in evolving an effective therapeutic program. Valuable information is acquired regarding time and type of onset, associated or provocative factors, the underlying mechanism ( fig.  5 ), and the efficacy of antiarrhythmic measures. When the patient is in the hospital long-range monitoring data can be readily acquired by a simple and inexpensive system. By attaching a time clock to a regular electrocardiograph adapted to print out at a speed of 1 mm/see, sampling can be obtained at any predetermined schedule. By selecting a lead system in which ectopic beats have opposite polarity to the normal complexes, the incidence of ventricular arrhythmia can be readily l 1 min assessed. This system has been designated as the 'poor man's" ectopic beat detector (EBD, figs. 6, 10).
Exercise Stress
This provides a safe and effective means for eliciting ventricular ectopic activity." Electrocardiographic monitoring during submaximal treadmill or bicycle exercise may expose the presence of arrhythmia not observed even after prolonged monitoring sessions. This technic yields immediate information as to whether the selected drug is effective.
Assessment of Efficacy of Digitalis Drugs
Left ventricular failure may be a contributory or even primary factor in recurrence of VT. This can be determined rapidly by means of an acetyl strophanthidin tolerance test when ventricular ectopic activity prevails between episodes of tachycardia ( fig. 10 ). If during such digitalization, ventricular extrasystoles diminish or disappear, it is likely that the tachyarrhythmia will be prevented by digitalis therapy. In the absence of ventricular extrasystoles, a trial period of digitalization is indicated in the patient with cardiomegaly.
Systemic Approach to Antiarrhythmic Drugs
It is necessary to deternine efficacy of a single drug. Once it is found that a particular agent does not induce immediate adverse effects, a large dose I AS 0 1Smg Figure is used, e.g., procaine amide 6.0 g daily or quinidine 1.8 g daily. When the arrhythmia recurs during the same time of day, large increments of the antiarrhythmic drug are given 1 or more hours before the expected recurrence, while small doses or even no drug at all is administered during the remainder of the day. If a number of antiarrhythmic drugs are individually ineffective, it is still worthwhile to employ them in combination.
Outpatient Management
One or more months may be necessary to work out an effective program. This is best accomplished outside the hospital.
Attention to Psychologic Problems
Recurrence of arrhythmia may result from emotional and nervous factors. At times no combination of drugs suffices until these problems are unravelled and the patient gains insight.
These six principles, when applied in concert, permit control of recurrent VT in the large majority of patients. What remains to be considered is the choice of an antiarrhythmic drug.
Procaine amide is the single most effective agent currently available. The drug is slowly hydrolyzed (10-25%/hr) to its major metabolites, diethylaminoethanol and p-aminobenzoic acid. About 60% of the drug is excreted by the kidneys largely unchanged with 2-10% of the administered dose recoverable in the urine as p-aminobenzoic acid. Thus, cumulative effects are likely when the drug is chronically administered to patients with congestive heart failure or impaired renal function. Antiarrhythmic effects occur at plasma levels of 4-8 ,g/ml, and these can be obtained by a daily dose of 50 mg/kg of body weight.45 To prevent subtherapeutic fluctuations in plasma level, the drug needs to be given at intervals of 3-4 hours. Serious adverse effects are very frequent and require discontinuation of therapy in as many as 60% who receive the drug chronically. 46 For recurrent VT, a daily dose of 3.0 g or greater is generally required. Doses as high as 10.5 g/day may be necessary.47 In one of our patients the arrhythmia could be prevented only when a dose of 12 g was taken daily. This amount was consumed continuously over a period of 3 years; thereafter, 4 g daily sufficed. Except for a metallic taste in the mouth, this patient has experienced no untoward effects. Though antinuclear antibody titer was markedly elevated, LE cells were never detected. Quinidine is nearly completely absorbed when given orally with peak action at 1-3 hours and dissipation of effect in about 6-8 hours. Quinidine and its hydroxylated metabolic products are excreted by the kidney within 24 hours. Therapeutic effects are achieved at blood concentrations above 2.5 ,gg/ml. Above 6.0 ,g/ml toxic reactions on the heart and cinchonism are common. 48 However, sudden death is known to occur when the maintenance dose is small and blood levels are well within the therapeutic range.49 In 12 of our 32 patients with recurrent VT, quinidine was the decisive agent.
From the electrophysiologic standpoint both procaine amide and quinidine behave similarly. These drugs prolong A-V and intraventricular conduction as well as increase duration of the Q-T interval (fig. 7 ). The diastolic threshold is increased, the strength interval curve is shifted to the right, and the effective refractory period is prolonged.56 There is a decrease in the maximum rising velocity of the action potential ( fig. 8 ). Diastolic depolarization in pacemaker fibers is slowed.
While electrophysiologic findings point to the similarities in fundamental effects of both quinidine and procaine amide, the clinician is well aware of striking differences in the action of these drugs on both atrial and ventricular arrhythmias. It is clear that when one of these agents fails, the other may still be effective.
Diphenylhydantoin (DPH). In order to exert optimal antiarrhythmic effect a blood level between 10 and 18 ,ug/ml is required.41 Administration of 400 mg daily, the usual practice, results in blood concentrations ranging from 2 to 5 .gg/ml and requires 6-9 days to achieve a therapeutic level.5' DPH differs in its electrophysiologic action from the quinidinelike antiarrhythmic drugs. In doses of up to 1 g daily it either decreases or leaves unchanged QRS duration, abbreviates the Q-T interval, and tends to shorten A-V conduction time.51 In therapeutic concentrations, DPH shortens action potential duration and refractoriness without appreciably affecting the depolarizing limb of the action potential ( fig. 7 ).52 Like other antiarrhythmics, it decreases the rate of slow diastolic depolarization. 53 A systematic study of the efficacy of DPH against recurring VT was carried out by Stone et al. 54 In 10 such patients who were carefully monitored electrocardiographically, there was no modification in frequency or duration of recurring episodes. Large loading doses of DPH were administered. All patients had blood levels in excess of 10.0 ,ug/ml and in five the plasma level exceeded 19.0 gg/ml.
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When VT is due to coronary artery disease, DPH is not an effective prophylactic drug.
Propranolol. Beta-blocking drugs have proved effective in a rninority of patients. In 14 patients with recurrent VT, propranolol alone was effective in three; however, when combined with quinidine, it was successful in eight where it failed when used as the only drug.55 Propranolol may prevent recurrent VT precipitated by exercise.56 Bretylium Tosylate. This quarternary benzylammonium salt has been recommended as a potent antiarrhythmic for the ventricular disorders which develop during acute myocardial infarction.57 58 It is an adrenergic neuronal blocking agent. It is poorly absorbed from the gastrointestinal tract. The duration of action varies between 6 and 24 hours depending on dose. 59 The major cardiovascular effects are biphasic with an initial sympathomimetic effect (tachycardia and increased cardiac output) followed by a sympatholytic response (brachycardia and hypotension), the latter being more marked.60 Bretylium differs from quinidinelike drugs in that it lacks local anesthetic properties and is devoid of significant effect on the transmembrane resting or action potential, overshoot, membrane responsiveness, or conduction velocity.6'
The drug is administered in a dose of 5 mg/kg i.m. every 6-12 hours. In an uncontrolled study, Day and Bacaner58 observed that 22 of 23 patients with acute myocardial infarction were free of arrhythmia after receiving bretylium. In a controlled study where bretylium was administered alternately to 101 patients with uncomplicated myocardial infarction, no difference was observed in mortality or in the incidence of serious arrhythmias including VT and VF.62 The drug had to be discontinued in 21 patients because of severe hypotension and in two because of syncope. This agent has not proved effective or practical for preventing recurrent VT outside the coronary care unit.
Overdrive. Increasing the heart rate in order to subdue ectopic mechanism is designated as overdrive.63 This was first employed by Zoll and co-workers64 in patients with Adams-Stokes syndrome suffering from recurring bouts of VT and VF. Sowton and co-workers65 introduced overdrive in patients without heart block. Accelerating the heart rate may prevent ventricular tachyarrhythmias. The rate of overdrive need not exceed that of the ectopic focus and generally can be set at a somewhat faster rate than that of the intrinsic sinus mechanism. When antiarrhythmic drugs are em-Circulation, Volume XLVII, June 1973 ployed as well, the pacing rate for effective control is reduced.43 When the required rate for overdrive is in excess of 100/min, there is an increased incidence of complications.
Overdrive finds its most useful application in the treatment of life-threatening arrhythmias refractory to pharmacologic agents. It is most useful as a temporary expedient to tide a patient over a brief stressful arrhythmic period such as occurs with acute myocardial infarction, drug intoxication, and postcardiac surgery. When the objective is to control frequently recurring VT, determining the efficacy of overdrive by means of a temporary pacing wire is mandatory before undertaking longterm pacing. This indicates whether pacing will prove effective, permits selection of an appropriate rate, and provides information as to whether antiarrhythmic drugs will be additionally required. Of the 32 patients in our series, pacing was attempted in 12, but in none was overdrive more than transiently effective. Overdrive is a new approach and is not a simple solution for recurring VT. It should be attempted only after a meticulous trial of drugs has failed. Surgical technics include essentially four approaches: sympathectomy,66 stellate ganglionectomy,67 aneurysmectomy,68 and aortocoronary bypass. In our series of 32 patients, aneurysmectomy was carried out in two. In one the operation was successful and the patient was free from VT for a period of 2 years only to die suddenly. The second patient died on the operating table. Surgical intervention is rarely indicated. It should be considered only when drugs and overdrive have failed to prevent recurrence.
Ventricular Flutter
Scherf and Schott69 have designated ventricular flutter as a rapid tachycardia where QRS and T are merged indistinguishably into one complex. In animals with myocardial infarction a similar disorder can be provoked by stimulating during the ventricular vulnerable period.70 This disorder has been designated as VT of the vulnerable period or VT(,,). In the dog susceptibility to VT(,p) persists for about 1 week following coronary artery ligation. Unlike VF, effective myocardial contractions continue as demonstrated by phasic variations in systemic pressure. Lower energy discharge is necessary to produce VT(,p) as compared to VF. It differs further in that VT(,p) can be terminated with one hundredth of the energy required to abolish VF. While the two mechanisms are distinct, PACEMAKER ARRHYTHMIAS St -St-840 R -R-960 Figure 7 QRS-inhibited ventricular pacemaker with rate hystersis. A slower natural rhythm (R-R cycle length of 960 msec) inhibits a faster automatic rate (St-St interval of 840 mesc). A reverse relationship is seen in pacemakers without this feature ( fig. 1, top) . majority of cases. At times unipolarization of a bipolar system is required. It should be emphasized that a good threshold for stimulation does not necessarily imply that sensing will be adequate. If voltages greater than 2.5 mv are not found, transvenous QRS-inhibited pacing should not be attempted.
Contrary to commonly held assumptions sensing is not an "all or nothing" phenomenon. Barold and co-workers have shown that the borderline intracavitary signals can produce an incomplete recycling of the sensing mechanism.20' [26] [27] [28] This phenomenon, called partial sensing, is characterized by escape intervals of longer duration than if the beat had not been detected at all, but of significantly shorter duration than when normal sensing occurs ( fig. 6 , fourth strip and fig. 8 ) .20, [26] [27] [28] Partial sensing can be seen in patients with normally functioning pacing systems if the intracardiac signals range between 1.5 and 5 mv. Yet the most frequent cause of partial sensing is improper electrode placement. Thus, repositioning of the electrodes, or unipolarization of the pacing system (and not pulse generator replacement) abolishes partial sensing. This diagnosis (as any problem involving sensing) can be confirmed by magnet conversion to continuous asynchronous pacing which will adequately differentiate between the stimulating and sensing abilities of the pacing system.26
Circulation, Volumne XL VII, Pacemaker Refractory Periods (PRP) All QRS-inhibited pacemakers have an "absolute" refractory period which can be different after emission of spike (delivery PRP) or after a sensed beat (sensing PR.P).24 Early QRS complexes will S PS Figure 8 Differences between "normal" and "partial' sensing. The escape intervals of "normally" sensed (S) beats are slightly longer (880 msec) and those of "partially" sensed (PS) QRS complexes are significantly shorter (610 msec) than the automatic intervals (840 msec). by cardiogenic shock is difficult to terminate, prone to recur, and a fatal outcome is almost invariable.
When VF occurs in a coronary or intensive care unit, the first objective should not be securing an airway or initiating external cardiac massage, but rather effecting electric reversion. The highest available energy is employed, for if lesser shock levels are used and fail, valuable seconds have been dissipated. An anteroposterior electrode paddle placement on the chest assures delivery of the maximal available energy. If VF recurs and the supraventricular rate between episodes is slow, addition of atropine is an important measure and should be given in a dose of 1.0 mg. Prevention of recurrence is treated in a manner similar to that outlined for VT. The patient who sustains but a single episode at the onset of myocardial infarction does not require long-term antiarrhythmic drug therapy.
